704257002: Product containing vedolizumab (medicinal product)

SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...

\Medicinal product categorized by disposition\Product containing selective adhesion molecule inhibitor\Product containing alpha-4 integrin receptor antagonist\Product containing vedolizumab
\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing vedolizumab

\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing antibody\Product containing monoclonal antibody\Product containing vedolizumab

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

3010812018 Vedolizumab en Synonym Inactive Entire term case insensitive SNOMED CT core module
3012301018 Vedolizumab (product) en Fully specified name Inactive Entire term case insensitive SNOMED CT core module
3522693013 Product containing vedolizumab (medicinal product) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3522694019 Product containing vedolizumab en Synonym Inactive Entire term case insensitive SNOMED CT core module
3669121018 Vedolizumab product en Synonym Inactive Entire term case insensitive SNOMED CT core module
3716978011 Vedolizumab-containing product en Synonym Active Entire term case insensitive SNOMED CT core module
107882001000001111 Vedolizumab en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom Edition module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing vedolizumab	Is a	Product containing monoclonal antibody	true	Inferred relationship	Existential restriction modifier
Product containing vedolizumab	Is a	Inflammatory bowel disease drug	false	Inferred relationship	Existential restriction modifier
Product containing vedolizumab	Is a	Product containing alpha-4 integrin receptor antagonist	true	Inferred relationship	Existential restriction modifier
Product containing vedolizumab	Has active ingredient	Vedolizumab	true	Inferred relationship	Existential restriction modifier	1
Product containing vedolizumab	Is a	Product containing immunomodulator	true	Inferred relationship	Existential restriction modifier
Product containing vedolizumab	Is a	Virtual therapeutic moiety	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Is a	False	Product containing vedolizumab	Inferred relationship	Existential restriction modifier
Vedolizumab	Is a	True	Product containing vedolizumab	Inferred relationship	Existential restriction modifier
Product containing vedolizumab in parenteral dose form (medicinal product form)	Is a	True	Product containing vedolizumab	Inferred relationship	Existential restriction modifier
Vedolizumab 108mg/0.68ml solution for injection pre-filled syringes	Is a	False	Product containing vedolizumab	Inferred relationship	Existential restriction modifier
Vedolizumab 108mg/0.68ml solution for injection pre-filled disposable devices	Is a	False	Product containing vedolizumab	Inferred relationship	Existential restriction modifier
Vedolizumab 300mg powder for solution for infusion vials	Is a	False	Product containing vedolizumab	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets